Association of Genetic Variants of CYP2C19 and CYP2D6 with Esophageal Squamous Cell Carcinoma Risk in Northern India, Kashmir

References

• Kamangar F, Chow WH, Abnet CC, and Dawsey SM: Environmental causes of esophageal cancer. Gastroenterol Clin North Am 38(1), 27–57, vii, 2009.
   PubMed Web of Science ®Google Scholar
• Louwman WJ, Aarts MJ, Houterman S, van Lenthe FJ, Coebergh JWW, et al.: A 50% higher prevalence of life-shortening chronic conditions among cancer patients with low socioeconomic status. Br J Cancer 103(11), 1742–1748, 2010.
   PubMed Web of Science ®Google Scholar
• Thrift AP, Nagle CM, Fahey PP, Russell AA, Smithers BM, et al.: The influence of prediagnostic demographic and lifestyle factors on esophageal squamous cell carcinoma survival. Int J Cancer 131(5), E759–E768, 2012.
   PubMed Web of Science ®Google Scholar
• Luo YP, Chen H, Khan MA, Chen F, Wan X, et al.: Genetic polymorphisms of metabolic enzymes-CYP1A1, CYP2D6, GSTM1, and GSTT1, and gastric carcinoma susceptibility. Tumour Biol 32(1), 215–222, 2011.
   PubMed Web of Science ®Google Scholar
• Crespi CL, Penman BW, Gelboin HV, and Gonzalez FJ: A tobacco smoke-derived nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, is activated by multiple human cytochrome P450s including the polymorphic human cytochrome P4502D6. Carcinogenesis 7, 1197–1201, 1991.
   Web of Science ®Google Scholar
• Mirvish SS: Role of N-nitroso compounds (NOC) and N-nitrosation in etiology of gastric, esophageal, nasopharyngeal and bladder cancer and contribution to cancer of known exposures to NOC. Cancer Lett 93(1), 17–48, 1995.
   PubMed Web of Science ®Google Scholar
• Smith TJ, Liao A, Wang L-D, Yang G-Y, Starcic S, et al.: Characterization of xenobiotic-metabolizing enzymes and nitrosamine metabolism in the human esophagus. Carcinogenesis 19, 667–672, 1998.
   PubMed Web of Science ®Google Scholar
• Abedi-Ardekani B, Kamangar F, Hewitt SM, Hainaut P, Sotoudeh M, et al.: Polycyclic aromatic hydrocarbon exposure in oesophageal tissue and risk of oesophageal squamous cell carcinoma in north-eastern Iran. Gut 59(9), 1178–1183, 2010.
   PubMed Web of Science ®Google Scholar
• Mao WM, Zheng WH, and Ling ZQ: Epidemiologic risk factors for esophageal cancer development. Asian Pac J Cancer Prev 12(10), 2461–2466, 2011.
   PubMedGoogle Scholar
• Rasool MT, Lone MM, Wani ML, Afroz F, Zaffar S, et al.: Cancer in Kashmir, India: burden and pattern of disease. J Cancer Res Ther 8(2), 243–246, 2012.
   PubMed Web of Science ®Google Scholar
• Khuroo MS, Zargar SA, Mahajan R, and Banday MA: High incidence of oesophageal and gastric cancer in Kashmir in a population with special personal and dietary habits. Gut 33(1), 11–15, 1992.
   PubMed Web of Science ®Google Scholar
• Dar NA, Bhat GA, Shah IA, Iqbal B, Kakhdoomi MA, et al.: Hookah smoking, nass chewing, and oesophageal squamous cell carcinoma in Kashmir, India. Br J Cancer 107(9), 1618–1623, 2012.
   PubMed Web of Science ®Google Scholar
• Dar NA, Bhat GA, Shah IA, Iqbal B, Rafiq R, et al.: Salt tea consumption and esophageal cancer: A possible role of alkaline beverages in esophageal carcinogenesis. Int J Cancer 2014.
   PubMed Web of Science ®Google Scholar
• Siddiqi MA, Tricker AR, Kumar R, Fazili Z, and Preussmann R: Dietary sources of N-nitrosamines in a high-risk area for oesophageal cancer–Kashmir, India. IARC Sci Publ 105, 210–213, 1991.
   Google Scholar
• Sambrook J, and Russell D: Molecular cloning: a laboratory manual. 2001.
   Google Scholar
• Bhat GA, Shah IA, Makhdoomi MA, Iqbal B, Rafiq R, et al.: CYP1A1 and CYP2E1 genotypes and risk of esophageal squamous cell carcinoma in a high-incidence region, Kashmir. Tumour Biol 2014.
   Web of Science ®Google Scholar
• De Morais SM, Wilkinson GR, Blaisdell J, Meyer UA, Nakamura K, et al.: Identification of a new genetic defect responsible for the polymorphism of (S)-mephenytoin metabolism in Japanese. Mol Pharmacol 46(4), 594–598, 1994.
   PubMed Web of Science ®Google Scholar
• Shi WX, and Chen SQ: Frequencies of poor metabolizers of cytochrome P450 2C19 in esophagus cancer, stomach cancer, lung cancer and bladder cancer in Chinese population. World J Gastroenterol 10(13), 1961–1963, 2004.
   PubMed Web of Science ®Google Scholar
• Sugimoto M, Furuta F, Shirai N, Nakamura A, Kajimura M, et al.: Poor metabolizer genotype status of CYP2C19 is a risk factor for developing gastric cancer in Japanese patients with Helicobacter pylori infection. Aliment Pharmacol Ther 22(10), 1033–1040, 2005.
   PubMed Web of Science ®Google Scholar
• Isomura Y, Yamaji Y, Ohta M, Seto M, Asaoka Y, et al.: A genetic polymorphism of CYP2C19 is associated with susceptibility to biliary tract cancer. J Gastroenterol Hepatol 45, 1045–1052, 2010.
   Google Scholar
• Shi Y, Luo G, Zhang L, Shi J, Zhang D, et al.: Interaction between alcohol consumption and CYP 2C19 gene polymorphism in relation to oesophageal squamous cell carcinoma. PLoS One 7(9), e43412, 2012.
   PubMed Web of Science ®Google Scholar
• Yadav SSR, Ruwali M, Pant MC, Shukla P, Singh RL, and Parmar D: Interaction of drug metabolizing cytochrome P450 2D6 poor metabolizers with cytochrome P450 2C9 and 2C19 genotypes modify the susceptibility to head and neck cancer and treatment response. Mutat Res 684, 49–55, 2010.
   PubMed Web of Science ®Google Scholar
• Gaikovitch EA, Cascorbi I, Mrozikiewicz PM, Brockmöller J, Frötschl R, et al.: Polymorphisms of drug-metabolizing enzymes CYP2C9, CYP2C19, CYP2D6, CYP1A1, NAT2 and of P-glycoprotein in a Russian population. Eur J Clin Pharmacol 59(4), 303–312, 2003.
   PubMed Web of Science ®Google Scholar
• Topić E, Štefanović M, Ivanišević AM, Petrinović R, and Čurčić I: The cytochrome P450 2D6 (CYP2D6) gene polymorphism among breast and head and neck cancer patients. Clin Chim Acta 296(1–2), 101–109, 2000.
   PubMed Web of Science ®Google Scholar
• Hirvonen A, Husgafvel-Pursiainen K, Anttila S, Karjalainen A, Pelkonen O, et al.: PCR-based CYP2D6 genotyping for Finnish lung cancer patients. Pharmacogenetics 3(1), 19–27, 1993.
   PubMedGoogle Scholar
• Dar NA, Shah IA, Bhat GA, Makhdoomi MA, Iqbal B, et al.: Socioeconomic status and esophageal squamous cell carcinoma risk in Kashmir, India. Cancer Sci 104(9), 1231–1236, 2013.
   PubMed Web of Science ®Google Scholar
• Laforest L, Wikman H, Benhamou S, Saarikoski ST, Bouchardy C, et al.: CYP2D6 gene polymorphism in caucasian smokers: lung cancer susceptibility and phenotype-genotype relationships. Eur J Cancer 36(14), 1825–1832, 2000.
   PubMed Web of Science ®Google Scholar
• Caporaso NE, Lerman C, Audrain J, Boyd NR, Main D, et al.: Nicotine metabolism and CYP2D6 phenotype in smokers. Cancer Epidemiol Biomarkers Prev 10(3), 261–263, 2001.
   PubMed Web of Science ®Google Scholar
• Zhang J, and Smith KR: Indoor air pollution: a global health concern. Br Med Bull 68, 209–225, 2003.
   PubMed Web of Science ®Google Scholar
• Tung Y.H., et al.: Cooking oil fume-induced cytokine expression and oxidative stress in human lung epithelial cells. Environ Res 87(1), 47–54, 2001.
   PubMed Web of Science ®Google Scholar
• Wornat MJ, Ledesma LB, and Sandrowitz AK: Polycyclic aromatic hydrocarbons identified in soot extracts from domestic coal-burning stoves of Henan Province, China. Environ Sci Technol 35(10), 1943–1952, 2001.
   PubMed Web of Science ®Google Scholar
• Ko JM, Zhang P, Law S, Fan Y, Song Y-Q: Identity-by-descent approaches identify regions of importance for genetic susceptibility to hereditary esophageal squamous cell carcinoma. Oncol Rep 32(2), 860–870, 2014.
   PubMed Web of Science ®Google Scholar
• Roth MJ, Wei W-Q, Baer J, Abnet CC, Wang G-Q, et al.: Aryl hydrocarbon receptor expression is associated with a family history of upper gastrointestinal tract cancer in a high-risk population exposed to aromatic hydrocarbons. Cancer Epidemiol Biomarkers Prev 18(9), 2391–2396, 2009.
   PubMed Web of Science ®Google Scholar